Accessibility Menu

NewcelX

(NASDAQ) NCEL

Current Price$3.81
Market Cap$20.58M
Since IPO (2025)-47%
5 Year-100%
1 Year-85%
1 Month+16%

NewcelX Financials at a Glance

Market Cap

$20.58M

Revenue (TTM)

$0.00

Net Income (TTM)

$144.07K

EPS (TTM)

-$17.34

P/E Ratio

-0.22

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$3.81

Volume

37,451

Open

$4.10

Previous Close

$3.85

Daily Range

$3.68 - $4.10

52-Week Range

$1.83 - $28.03

Estimated Earnings Date

May 15, 2026

NCEL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NewcelX

Industry

Biotechnology

Employees

12

CEO

Ronen Twito

Headquarters

Zurich, 8058, CH

NCEL Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

41.94%

Return on Capital

-32.53%

Return on Assets

18.57%

Earnings Yield

-4.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.58M

Shares Outstanding

5.35M

Volume

37.45K

Avg. Volume

55.01K

Financials (TTM)

Gross Profit

-$5.31K

Operating Income

-$10.26M

EBITDA

-$6.74M

Operating Cash Flow

-$6.34M

Capital Expenditure

-$3.93K

Free Cash Flow

-$6.35M

Cash & ST Invst.

$2.20M

Total Debt

$355.00K

NewcelX Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$20.58M

N/A

Market Cap/Employee

$1.87M

N/A

Employees

11

N/A

Net Income

$4.35M

+95418.0%

EBITDA

-$998.22K

+76.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$2.20M

+145.2%

Total Debt

$355.00K

-78.3%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$355.00K

-78.3%

Return on Assets

18.57%

N/A

Return on Invested Capital

-81.09%

N/A

Free Cash Flow

-$1.98K

+16.9%

Operating Cash Flow

-$1.98K

+17.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CELUCelularity Inc.
$0.62+2.55%
KTTAPasithea Therapeutics Corp.
$0.55-3.02%
SABSSAB Biotherapeutics, Inc.
$3.92+1.03%
NUWENuwellis, Inc.
$3.15+0.32%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.35-0.05%

Questions About NCEL

What is the current price of NewcelX?

NewcelX is trading at $3.85 per share.

What is the 52-week range for NewcelX?

Over the past 52 weeks, NewcelX has traded between $1.83 and $28.03.

How much debt does NewcelX have?

As of the most recent reporting period, NewcelX reported total debt of $355.00K.

How much cash does NewcelX have on hand?

NewcelX reported $2.20M in cash and cash equivalents in its most recent financial results.

What is NewcelX’s dividend yield?

NewcelX does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.